Advanced Therapy Medicinal Products Market to Reach $9.6 Billion by 2026 | Key Players Spark Therapeutics, Inc.; Bluebird Bio, Inc.; Novartis AG;…

Posted: April 22, 2020 at 5:41 pm

Grand View Research, Inc. Market Research And Consulting

According to report published by Grand View Research, The global advanced therapy medicinal products market size was valued at USD 3.14 billion in 2019 and is projected to expand at a CAGR of 17.4% during the forecast period

The globaladvanced therapy medicinal products marketsize is expected to reach USD 9.6 billion by 2026, expanding at a CAGR of 17.4% over the forecast period, according to a new report published by Grand View Research, Inc. The use of advanced therapy medicinal products (ATMPs) is well-proven for the improvement in the quality of life and health status in the long run for patients suffering from life-threatening conditions. This is particularly for diseases with few or no alternative treatment options. These novel treatment modes deliver transformative advantages not offered by conventional forms of disease treatment, thereby driving the ATMP market.

In the current scenario, ATMPs are expensive for patients as well as health insurance schemes. Growing competition to gain revenue share could help reduce prices and improve the affordability, along with the acceptance of these products as mainstream medicine. Furthermore, manufacturers are embracing efforts to streamline technology and logistics for the provision of therapies at accessible prices.

Request a sample Copy of the Global Advanced Therapy Medicinal Products Market Research Report @ http://www.grandviewresearch.com/industry-analysis/advanced-therapy-medicinal-products-market/request/rs1

Moreover, lack of manufacturing capabilities to meet growing consumer demand coupled with the resource and budget constraints faced by advanced therapy medicinal product developers has created lucrative avenues for contract services providers and has intensified the market competition. This has led to a rise in market activities by contract service providers. For instance, in November 2019, Fujifilm Diosynth established a 60,000-square-feet Gene Therapy Innovation Center to offer downstream, upstream, and analytical services.

Further key findings from the report suggest:

Have Any Query? Ask Our Experts @www.grandviewresearch.com/inquiry/7111/ibb

Grand View Research has segmented the global advanced therapy medicinal products market on the basis of therapy type and region:

Advanced Therapy Medicinal ProductsTherapy Type Outlook (Revenue, USD Million, 2015 2026)

Advanced Therapy Medicinal ProductsRegional Outlook (Revenue, USD Million, 2015 2026)

Browse Related Category @

Nuclear Medicine Market http://www.grandviewresearch.com/industry-analysis/nuclear-medicines-market

Aromatherapy Carrier Oil Market http://www.grandviewresearch.com/industry-analysis/aromatherapy-carrier-oil-market

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research Guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address: 201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: https://www.grandviewresearch.com/industry-analysis/advanced-therapy-medicinal-products-market

Read more:
Advanced Therapy Medicinal Products Market to Reach $9.6 Billion by 2026 | Key Players Spark Therapeutics, Inc.; Bluebird Bio, Inc.; Novartis AG;...

Related Posts

Comments are closed.

Archives